Case Study | June 15, 2012

Challenges In Japan On Post-Marketing Surveillance: Observational Study And EPPV Program Case Study

Source: Pharma IQ

In a session that will be discussed in detail at the 3rd Annual Pharmacovigilance Asia 2012, Dr. Shinichi Nishiuma, Senior Medical Advisor & Lead physician of Global Patient Safety in Japan for Lilly Research Laboratories Japan, talks about the future challenges in Japan’s pharmacovigilance market with Bryan Camoens.

For full access to this content, please Register or Sign In.

Access Content Challenges In Japan On Post-Marketing Surveillance: Observational Study And EPPV Program Case Study